Data as of Jan 23
| -0.0508 / -2.03%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 13.50, with a high estimate of 16.00 and a low estimate of 11.00. The median estimate represents a +451.20% increase from the last price of 2.45.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.